RTALB.E — RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Market Cap
TRY1.29bn
Enterprise Value
TRY1.21bn
Revenue
TRY86.03m

Annual balance sheet for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	R2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.19	12.4	18.4	163	149
Net Total Accounts Receivable
Net Total Receivables	19.5	16.4	84.9	158	97.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32.9	34.6	143	369	301
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.2	14.8	31.4	46.8	53.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	65.6	98.2	257	552	740
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.63	7.81	82.5	205	88.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	6.1	11.5	106	240	146
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	59.5	86.6	150	313	595
Total Liabilities & Shareholders' Equity	65.6	98.2	257	552	740
Total Common Shares Outstanding